Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221409

Medchemexpress LLC 1-[4-[(2S)-2-(morpholin-4-ylmethyl)pyrrolidin-1-yl]sulfonylphenyl]-3-[4-(trifluoromethyl)phenyl]urea | 2230496-99-6 | 99.9% | 512.55 | C23H27F3N4O4S | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1453105MG

Encompass_Preferred

ZL0590 is a potent, orally active small-molecule inhibitor selective for the BRD4 BD1 bromodomain. It has an IC50 of approximately 90 nM against human BRD4 BD1 and demonstrates anti-inflammatory efficacy in preclinical models, making it suitable for research into bromodomain biology and inflammatory disease mechanisms.

  • Potent BRD4 BD1 inhibition (IC50 ≈ 90 nM)
  • Selective for BD1 over other bromodomains
  • Demonstrated anti-inflammatory activity in animal models
  • Appropriate for in vitro and in vivo research applications
  • Soluble in DMSO for solution preparation
  • High chemical purity (~99.9%)

Catalog No. 50-002-21409


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.